Previous 10 | Next 10 |
– Agreement Underscores Board’s Commitment to Aligning Executive Compensation with Shareholder Returns – DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2023 (GLOBE NEWSWIRE) -- Today the Board of Directors of Amarin Corporation plc (NASDAQ: AMRN) announced details ...
2023-07-19 10:22:17 ET Gainers: Panbela Therapeutics ( PBLA ) +36% . 60 Degrees Pharmaceuticals ( SXTP ) +20% . CareMax ( CMAX ) +20% . Biodexa Pharmaceuticals ( BDRX ) +13% . bluebird bio ( BLUE ) +13% . Losers: Amar...
2023-07-19 08:30:52 ET Aqua Metals ( AQMS ) -27% after disclosing stock offering . Amarin Corporation ( AMRN ) -20% on plan to undergo restructuring . Biophytis ( BPTS ) -18% on $3.8M offering . Genprex ( GNPX ) -14% on $7.5 Millio...
2023-07-18 16:24:34 ET Pharmaceutical company Amarin Corporation ( NASDAQ: AMRN ) said on Tuesday that that its board has appointed Patrick Holt president, CEO and board member, effective immediately. Interim President and CEO Aaron Berg will remain with the company ...
DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced that the Company’s Board of Directors has appointed Patrick Holt as President and Chief Executive Officer and as a member of the Board of Directors, effective imme...
-- Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources -- -- Maximizes Cash Flow Opportunity Through Streamlined Model in U.S. -- -- Company Expects Restructuring to Drive Annual Cost Savings of Approximately $40 Milli...
2023-06-26 16:14:03 ET Summary Amarin recently acquired a completely revamped management. There seems to be no radical shift in strategy, however. Therefore, there is no radical change in my negative opinion on the outlook. In my previous article , we saw Sarissa...
-- VASCEPA ® Approved in KSA To Reduce the Risk of Cardiovascular (CV) Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT-- -- VASCEPA Becomes First and ...
2023-06-13 03:39:06 ET Start Time: 17:40 End Time: 18:14 Amarin Corporation plc (AMRN) Goldman Sachs 44th Annual Global Healthcare Conference June 12, 2023, 17:40 PM ET Company Participants Aaron Berg - Interim President and CEO Tom Reilly - CFO Confere...
2023-06-07 11:51:09 ET Amarin Corporation plc (AMRN) Jefferies 2023 Global Healthcare Conference June 7, 2023 8:00 AM ET Company Participants Aaron Berg - Interim CEO & President Tom Reilly - CFO Conference Call Participants Michael Yee - Jefferies ...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...